ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

A Dzikiewicz-Krawczyk; K Kok; I Slezak-Prochazka; J-L Robertus; J Bruining; M M Tayari; B Rutgers; D de Jong; J Koerts; A Seitz; Jun Li; B Tillema; J. Guikema; I M Nolte; A Diepstra; Lydia Visser; J Kluiver; A. van den Berg

doi:10.1038/leu.2017.94

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

A Dzikiewicz-Krawczyk, K Kok, I Slezak-Prochazka, J-L Robertus, J Bruining, M M Tayari, B Rutgers, D de Jong, J Koerts, A Seitz, Jun Li, B Tillema, J. Guikema, I M Nolte, A Diepstra, Lydia Visser, J Kluiver, A. van den Berg

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

40 Citations (Scopus)

784 Downloads (Pure)

Abstract

Original language	English
Pages (from-to)	1470-1473
Number of pages	4
Journal	Leukemia
Volume	31
Early online date	7-Apr-2017
DOIs	https://doi.org/10.1038/leu.2017.94
Publication status	Published - Jul-2017

Keywords

RNAS
CELL-CYCLE
C-MYC
MIR-150

Access to Document

10.1038/leu.2017.94

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphomaFinal author's version, 12.3 MB

Handle.net

Persistent link

Embargoed Document

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB
Final publisher's version, 223 KB

Cite this

Dzikiewicz-Krawczyk, A., Kok, K., Slezak-Prochazka, I., Robertus, J.-L., Bruining, J., Tayari, M. M., Rutgers, B., de Jong, D., Koerts, J., Seitz, A., Li, J., Tillema, B., Guikema, J., Nolte, I. M., Diepstra, A., Visser, L., Kluiver, J., & van den Berg, A. (2017). ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. Leukemia, 31, 1470-1473. https://doi.org/10.1038/leu.2017.94

@article{a82a227eff074bedac5485f4ea684ca7,

title = "ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma",

keywords = "RNAS, CELL-CYCLE, C-MYC, MIR-150",

author = "A Dzikiewicz-Krawczyk and K Kok and I Slezak-Prochazka and J-L Robertus and J Bruining and Tayari, {M M} and B Rutgers and {de Jong}, D and J Koerts and A Seitz and Jun Li and B Tillema and J. Guikema and Nolte, {I M} and A Diepstra and Lydia Visser and J Kluiver and {van den Berg}, A.",

year = "2017",

month = jul,

doi = "10.1038/leu.2017.94",

language = "English",

volume = "31",

pages = "1470--1473",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

Dzikiewicz-Krawczyk, A, Kok, K, Slezak-Prochazka, I, Robertus, J-L, Bruining, J, Tayari, MM, Rutgers, B, de Jong, D, Koerts, J, Seitz, A, Li, J, Tillema, B, Guikema, J, Nolte, IM , Diepstra, A , Visser, L , Kluiver, J & van den Berg, A 2017, 'ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma', Leukemia, vol. 31, pp. 1470-1473. https://doi.org/10.1038/leu.2017.94

TY - JOUR

T1 - ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

AU - Dzikiewicz-Krawczyk, A

AU - Kok, K

AU - Slezak-Prochazka, I

AU - Robertus, J-L

AU - Bruining, J

AU - Tayari, M M

AU - Rutgers, B

AU - de Jong, D

AU - Koerts, J

AU - Seitz, A

AU - Li, Jun

AU - Tillema, B

AU - Guikema, J.

AU - Nolte, I M

AU - Diepstra, A

AU - Visser, Lydia

AU - Kluiver, J

AU - van den Berg, A.

PY - 2017/7

Y1 - 2017/7

KW - RNAS

KW - CELL-CYCLE

KW - C-MYC

KW - MIR-150

U2 - 10.1038/leu.2017.94

DO - 10.1038/leu.2017.94

M3 - Comment/Letter to the editor

C2 - 28331227

SN - 0887-6924

VL - 31

SP - 1470

EP - 1473

JO - Leukemia

JF - Leukemia

ER -